E
Ensysce Biosciences, Inc. (ENSC)
NCM – Real Time Price. Currency in USD
0.30
+0.02 (6.33%)
At close: Jun 26, 2026, 4:00 PM EDT
0.31
+0.01 (2.86%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.30
+0.02 (6.33%)
At close: Jun 26, 2026, 4:00 PM EDT
0.31
+0.01 (2.86%)
After-hours: Jun 26, 2026, 7:45 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $745.5K significantly exceed its total debt $216.0K, ensuring strong financial flexibility
Total current liabilities $2.8M surpass Total current assets $2.0M, signaling liquidity issues
Debt-to-equity ratio (-0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-908.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.71 | 6.05 | 4.0 | |
| Quick ratio | 0.71 | 5.63 | 4.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.10 | 1.04 | 9.0 | |
| Interest coverage | -908.04 | -16.91 | 1.0 | |
| Weighted average score | 3.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 2M | 5M | 5M | 5M |
| Gross Profit | N/A | N/A | N/A | N/A | 954K |
| Operating Income | -24M | -11M | -7M | -10M | -12M |
| Net Income | -24M | -11M | -8M | -10M | -12M |
| EBITDA | -24M | -11M | -7M | -10M | -12M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 36.71 | 5.5 |
| Next quarter | 285.31 | 62.02 | 10 |
| Current year | 33.33 | 50.25 | 10 |
| Next year | -63.24 | 94.44 | 5.5 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -48.94 | -28.49 | 30.67 | -129.43 | 3.3 |
| Y/Y | -27.17 | -82.79 | 62.59 | -105.03 | 3.3 |
| 3y average | 39.75 | 17.81 | 69.53 | 21.48 | 9.8 |
| 5y average | 16.11 | -10252.08 | 60.79 | -122.66 | 5.3 |
| Weighted average score | 5.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |